Abstract
In a double-blind, placebo-controlled study, we used 1H MR spectroscopy to assess the effect of a single infusion of sodium dichloroacetate on lesion lactate 1 to 5 days after ischemic stroke. Apparent trends toward a reduction in lactate/N-acetyl compound ratios were seen at the higher drug doses employed, and in patients treated in the first 2 days following infarction. Use of spectroscopic measures as endpoints is feasible in acute stroke clinical trials.
Original language | English (US) |
---|---|
Pages (from-to) | 1376-1378 |
Number of pages | 3 |
Journal | Neurology |
Volume | 55 |
Issue number | 9 |
DOIs | |
State | Published - Nov 14 2000 |
Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology